|Grant ID: RR170010|
Recruitment of First-Time, Tenure-Track Faculty Members
Massachusetts Institute of Technology
February 15, 2017
Prostate cancer is the second leading cause of death in American men, and often requires the male hormone testosterone in order to grow. When caught early, most prostate cancer can be cured through surgery and hormone reduction. But there is no treatment for so-called “castration-resistant” prostate cancer, which does not respond to testosterone depletion and will continue to grow.
Now a molecular biologist at the University of Texas Southwestern Medical Center is trying to understand how DNA breaks at specific locations contribute to the progression of prostate cancer. Ultimately, these studies could lead to new therapies for prostate cancer, including castration-resistant forms.
Ram Madabhushi was recruited in 2017 from the Massachusetts Institute of Technology, where he was a postdoctoral fellow, with the help of a First-Time Tenure-Track Award from CPRIT.